TerminatedNCT00946985
Official study titleA Prospective, Randomized, Active-controlled, Rater-blinded Study of the Prevention of Relapse Comparing Paliperidone Palmitate With Oral Risperidone in Adults With Recently-Diagnosed Schizophrenia Who Are at High Risk of Relapse
This study ended early.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–35
- Countries
- United States, Canada, Brazil, + 9 others
- Sponsor
- Ortho-McNeil Janssen Scientific Affairs, LLC
CompletedNCT00159744
Official study titleA Phase III, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Safety and Efficacy of Sublingual Asenapine vs. Olanzapine and Placebo in In-Patients With an Acute Manic Episode Clinical Trial Protocol 7501004 (Secondary Title: ARES)
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18+
- Countries
- Sponsor
- Organon and Co
CompletedNCT00159796
Official study titleA Phase III, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Safety and Efficacy of Sublingual Asenapine vs. Olanzapine and Placebo in In-Patients With an Acute Manic Episode Clinical Trial Protocol 7501005 (Secondary Title: ARES)
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18+
- Countries
- Sponsor
- Organon and Co
CompletedNCT00312494
Official study titleA Three-Week, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Efficacy and Safety of Add-On Oral Ziprasidone in Subjects With Acute Mania Treated With Lithium or Divalproex
This study has finished and is no longer accepting participants.
Multiple locations, including DothanBipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
CompletedNCT02220504
Official study titleClinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-episode Non-affective Psychosis Individuals: A 3-year Follow-up
This study has finished and is no longer accepting participants.
In SantanderSchizophreniaInterventional studyAges 15–60
- Countries
- Spain
- Sponsor
- Fundación Marques de Valdecilla
WithdrawnNCT06557759
Official study titleThe Effect of Listening to 30-Minutes of Calming Music on Mental Health Professionals
This study was withdrawn before enrollment.
Location not clearly listedAnxiety, DepressionBehavioural studyAges 18–89
- Countries
- Sponsor
- University of Florida
CompletedNCT01706380
Official study titleA Randomized Controlled Trial of Interactive Voice Response With and Without Personal Feedback in the Treatment of Adolescents With Substance Use Disorders
This study has finished and is no longer accepting participants.
In MalmöAddictionBehavioural studyUp to age 25
- Countries
- Sweden
- Sponsor
- Region Skane
CompletedNCT03796936
Official study titleClinical Trial of 3MDR to Treat PTSD With mTBI, With and Without Eye Movement (3MDR)
This study has finished and is no longer accepting participants.
In BethesdaPTSDBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Walter Reed National Military Medical Center
UnknownNCT06498999
Official study titleDevelopment and Validation of a 4-STEP-Training Program for Social Media Addiction (4-STEP-TPS) Among Young Adults: A Randomized Control Trial
Current recruitment status is unconfirmed.
In FaisalābadAddictionBehavioural studyAges 18–30
- Countries
- Pakistan
- Sponsor
- Government College University Faisalabad
CompletedNCT00159783
Official study titleA Double-Blind, 40-Week Continuation Study Evaluating the Safety of Asenapine and Olanzapine in the Treatment of Subjects With Acute Mania Clinical Trial Protocol A7501007 (Secondary Title: ARES)
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18+
- Countries
- Sponsor
- Organon and Co
CompletedNCT00145509
Official study titleA Phase 3, Placebo-Controlled, Double-Blinded Continuation Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Completing a 12-week Lead-in Trial and Continuing Lithium or Valproic Acid/Divalproex Sodium for the Treatment of an Acute Manic or Mixed Episode
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18+
- Countries
- Sponsor
- Organon and Co
CompletedNCT02876757
This study has finished and is no longer accepting participants.
Location not clearly listedDepressionObservational studyAges 66–120
- Countries
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
